U-Neuron Biomedical (ROCO:6973) Scaled Net Operating Assets : 0.05 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

U-Neuron Biomedical's operating assets for the quarter that ended in Dec. 2023 was NT$47.21 Mil. U-Neuron Biomedical's operating liabilities for the quarter that ended in Dec. 2023 was NT$21.54 Mil. U-Neuron Biomedical's Total Assets for the quarter that ended in Jun. 2023 was NT$539.49 Mil. Therefore, U-Neuron Biomedical's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.05.

U-Neuron Biomedical Scaled Net Operating Assets Historical Data

The historical data trend for U-Neuron Biomedical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Scaled Net Operating Assets Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.14

-0.01

0.02

0.14

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Scaled Net Operating Assets	-0.01	-	-	0.05	0.05

Competitive Comparison of U-Neuron Biomedical's Scaled Net Operating Assets

For the Biotechnology subindustry, U-Neuron Biomedical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's Scaled Net Operating Assets falls into.

U-Neuron Biomedical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

U-Neuron Biomedical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(47.212	-	21.539)	/	186.302
=	0.14

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	523.169	-	475.957
=	47.212

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	31.202	-	4.896	-	4.767
=	21.539

U-Neuron Biomedical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Jun. 2023 )
=	(47.212	-	21.539)	/	539.491
=	0.05

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	523.169	-	475.957
=	47.212

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	31.202	-	4.896	-	4.767
=	21.539

U-Neuron Biomedical Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines